Detalles de la búsqueda
1.
Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy.
J Clin Oncol
; 19(12): 3029-36, 2001 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11408498
2.
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
J Clin Oncol
; 21(22): 4083-91, 2003 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14568987
3.
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
J Clin Oncol
; 20(8): 2031-7, 2002 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11956262
4.
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
J Cancer Res Clin Oncol
; 131(4): 255-60, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15627215
5.
Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro.
Eur J Cancer
; 31A(1): 92-7, 1995.
Artículo
en Inglés
| MEDLINE | ID: mdl-7695986
6.
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
Eur J Cancer
; 39(6): 775-82, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12651203
7.
Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic.
Semin Oncol
; 27(1 Suppl 1): 8-13, 2000 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-10697038
8.
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.
Ann Oncol
; 16(8): 1326-33, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15919686
9.
Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
Br J Cancer
; 74(2): 224-8, 1996 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-8688325
10.
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines.
Anticancer Drugs
; 6(5): 681-5, 1995 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8845478
11.
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.
Br J Cancer
; 87(10): 1066-71, 2002 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-12402143
12.
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
Anticancer Drugs
; 11(7): 535-9, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-11036955
13.
Comparison between short or long exposure to 5-fluorouracil in human gastric and colon cancer cell lines: biochemical mechanism of resistance.
Anticancer Drugs
; 9(7): 625-34, 1998 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9773807
14.
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines.
Br J Cancer
; 81(8): 1304-10, 1999 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-10604726
15.
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Br J Cancer
; 89(1): 29-35, 2003 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-12838296
16.
Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study.
Ann Oncol
; 14(9): 1442-8, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12954586
17.
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Ann Oncol
; 11(5): 553-9, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10907948
18.
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors.
Ann Oncol
; 15(8): 1284-94, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15277271
Resultados
1 -
18
de 18
1
Próxima >
>>